Seroatlas · Human Serome Atlas

GCDH

Glutaryl-CoA dehydrogenase, mitochondrial

Also known as: ACAD5, GCD, GCDH_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q92947
Gene
GCDH
Ensembl
ENSG00000105607
Chromosome
19
Canonical length
438 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria
Quaternary structure
Homotetramer

OverviewNCBI Gene

The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013]

Canonical amino-acid sequenceUniProt

438 residues, UniProt reviewed canonical sequence.

>Q92947|GCDH
     1  MALRGVSVRL LSRGPGLHVL RTWVSSAAQT EKGGRTQSQL AKSSRPEFDW QDPLVLEEQL
    61  TTDEILIRDT FRTYCQERLM PRILLANRNE VFHREIISEM GELGVLGPTI KGYGCAGVSS
   121  VAYGLLAREL ERVDSGYRSA MSVQSSLVMH PIYAYGSEEQ RQKYLPQLAK GELLGCFGLT
   181  EPNSGSDPSS METRAHYNSS NKSYTLNGTK TWITNSPMAD LFVVWARCED GCIRGFLLEK
   241  GMRGLSAPRI QGKFSLRASA TGMIIMDGVE VPEENVLPGA SSLGGPFGCL NNARYGIAWG
   301  VLGASEFCLH TARQYALDRM QFGVPLARNQ LIQKKLADML TEITLGLHAC LQLGRLKDQD
   361  KAAPEMVSLL KRNNCGKALD IARQARDMLG GNGISDEYHV IRHAMNLEAV NTYEGTHDIH
   421  ALILGRAITG IQAFTASK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GCDH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
87 nTPM

Expression across tissuesHPA

Tissue

  • liver: 87 nTPM
  • choroid plexus: 30 nTPM
  • skeletal muscle: 28 nTPM
  • heart muscle: 28 nTPM
  • tongue: 25 nTPM
  • kidney: 23 nTPM

Single-cell type

  • hepatocytes: 154 nCPM
  • breast lactating cells: 74 nCPM
  • bergmann glia: 53 nCPM
  • esophageal basal cells: 39 nCPM
  • ovarian stromal cells: 37 nCPM
  • parietal cells: 35 nCPM

Immune cell

  • NK-cell: 39 nTPM
  • naive CD4 T-cell: 31 nTPM
  • myeloid DC: 24 nTPM
  • naive CD8 T-cell: 24 nTPM
  • memory CD4 T-cell: 23 nTPM
  • T-reg: 21 nTPM

Brain region

  • white matter: 25 nTPM
  • basal ganglia: 25 nTPM
  • cerebellum: 24 nTPM
  • choroid plexus: 24 nTPM
  • medulla oblongata: 22 nTPM
  • cerebral cortex: 22 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GCDH.

Disease | AllUniProt

Conditions GCDH is implicated in, by any mechanism.

Disease | GeneticClinVar

328 pathogenic / likely-pathogenic of 1,035 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.64
gnomAD pLI
0
gnomAD missense Z
0.31
DepMap mean gene effect
-0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GCDH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GCDH as an antibody target. Whether an autoantibody or antibody against GCDH could matter depends on whether native GCDH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GCDH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GCDH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GCDH. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...